Lexaria Bioscience Corp. (LEXX)

NASDAQ: LEXX · Real-Time Price · USD

Compare

0.7009

-0.0088 (-1.24%)

At close: Jan 6, 2026, 4:00 PM EST

0.6750

-0.0259 (-3.70%)

After-hours: Jan 6, 2026, 7:56 PM EST

Lexaria Bioscience Market Cap

Lexaria Bioscience has a market cap or net worth of $17.44 million as of January 6, 2026. Its market cap has decreased by -52.60% in one year.

Market Cap

17.44M

Enterprise Value

15.59M

1-Year Change

-52.60%

Ranking

#4981

Market Cap Chart

Since February 12, 2007, Lexaria Bioscience's market cap has decreased from $19.40M to $17.44M, a decrease of -10.08%. That is a compound annual growth rate of -0.56%.

Market Cap History

Date	Market Cap	% Change
Jan 6, 2026	15.60M	13.87%
Dec 31, 2025	13.70M	-62.67%
Dec 31, 2024	36.70M	186.72%
Dec 29, 2023	12.80M	-12.33%
Dec 30, 2022	14.60M	-36.80%
Dec 31, 2021	23.10M	2.67%
Dec 31, 2020	22.50M	-24.75%
Dec 31, 2019	29.90M	-58.30%
Dec 31, 2018	71.70M	-38.87%
Dec 29, 2017	117.30M	624.07%
Dec 30, 2016	16.20M	131.43%
Dec 31, 2015	7.00M	125.81%
Dec 31, 2014	3.10M	342.86%
Dec 31, 2013	700.00K	-12.50%
Dec 31, 2012	800.00K	-77.78%
Dec 30, 2011	3.60M	-7.69%
Dec 31, 2010	3.90M	69.57%
Dec 31, 2009	2.30M	130.00%
Dec 31, 2008	1.00M	-94.71%
Dec 31, 2007	18.90M	-2.58%
Feb 12, 2007	19.40M	-

View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	932.55B
Johnson & Johnson	492.24B
AbbVie	389.14B
UnitedHealth Group	309.81B
AstraZeneca	280.48B
Merck & Co.	266.67B
Novartis AG	262.61B
Novo Nordisk	241.55B

Market Cap Rankings